Cliff Asness’s TECH Holdings & Trades

First Buy
Q4 2014
Duration Held
44 Quarters
Largest Add
Q4 2018
+585,644 shares
Current Position
18,354 shares
$969,100 value

Cliff Asness's TECH Position Overview

Cliff Asness (via Aqr Capital Management LLC) currently holds 18.4K shares of Bio-Techne Corporation (TECH) worth $969,100, representing 0.00% of the portfolio. First purchased in 2014-Q4, this long-term strategic position has been held for 44 quarters.

Based on 13F filings since 2013, Cliff Asness has maintained a long-term strategic position in TECH, representing a significant commitment to this investment thesis. Largest addition occurred in Q4 2018, adding 585.6K shares. Largest reduction occurred in Q1 2019, reducing 681.3K shares.

Analysis based on 13F filings available since 2013 Q2

Cliff Asness's Bio-Techne Corporation (TECH) Holding Value Over Time

Track share changes against reported price movement

Quarterly Bio-Techne Corporation (TECH) Trades by Cliff Asness

Period Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q4 2014 +62,972 New Buy 62,972 $23.11
Q1 2015 -37,772 Reduce 59.98% 25,200 $25.08
Q3 2015 -25,200 Sold Out 25,200 $0.00
Q3 2016 +18,808 New Buy 18,808 $27.38
Q4 2016 -18,808 Sold Out 18,808 $0.00
Q1 2017 +30,832 New Buy 30,832 $25.43
Q2 2017 -608 Reduce 1.97% 30,224 $29.38
Q3 2017 -4,876 Reduce 16.13% 25,348 $30.22
Q4 2017 +9,996 Add 39.44% 35,344 $32.23
Q1 2018 +183,116 Add 518.10% 218,460 $37.76
Q2 2018 +235,392 Add 107.75% 453,852 $36.99
Q3 2018 +451,784 Add 99.54% 905,636 $51.03
Q4 2018 +585,644 Add 64.67% 1.49 M $36.18
Q1 2019 -681,332 Reduce 45.69% 809,948 $49.55
Q2 2019 -25,380 Reduce 3.13% 784,568 $51.69
Q3 2019 -289,164 Reduce 36.86% 495,404 $48.92
Q4 2019 -184,972 Reduce 37.34% 310,432 $54.35
Q1 2020 +80,172 Add 25.83% 390,604 $47.41
Q2 2020 -132,524 Reduce 33.93% 258,080 $63.92
Q3 2020 -32,068 Reduce 12.43% 226,012 $61.93
Q4 2020 -604 Reduce 0.27% 225,408 $79.37
Q1 2021 -46,192 Reduce 20.49% 179,216 $95.48
Q2 2021 -41,288 Reduce 23.04% 137,928 $111.64
Q3 2021 +44,168 Add 32.02% 182,096 $121.14
Q4 2021 +59,764 Add 32.82% 241,860 $127.20
Q1 2022 -70,492 Reduce 29.15% 171,368 $108.26
Q2 2022 -9,280 Reduce 5.42% 162,088 $85.40
Q3 2022 -16,264 Reduce 10.03% 145,824 $71.00
Q4 2022 +18,957 Add 13.00% 164,781 $82.80
Q1 2023 -82,154 Reduce 49.86% 82,627 $73.50
Q2 2023 -46,404 Reduce 56.16% 36,223 $81.00
Q3 2023 +5,392 Add 14.89% 41,615 $68.07
Q4 2023 +18,746 Add 45.05% 60,361 $77.16
Q1 2024 -9,272 Reduce 15.36% 51,089 $69.87
Q2 2024 -859 Reduce 1.68% 50,230 $71.65
Q3 2024 +7,861 Add 15.65% 58,091 $79.07
Q4 2024 +61 Add 0.11% 58,152 $72.03
Q1 2025 -49,935 Reduce 85.87% 8,217 $57.39
Q2 2025 +6,055 Add 73.69% 14,272 $51.45
Q3 2025 +4,082 Add 28.60% 18,354 $52.80

Cliff Asness's Bio-Techne Corporation Investment FAQs

Cliff Asness first purchased Bio-Techne Corporation (TECH) in Q4 2014, acquiring 62,972 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Cliff Asness has held Bio-Techne Corporation (TECH) for 44 quarters since Q4 2014. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Cliff Asness's largest addition to Bio-Techne Corporation (TECH) was in Q4 2018, adding 1,491,280 shares worth $53.96 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

According to the latest 13F filing for Q3 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 18,354 shares of Bio-Techne Corporation (TECH), valued at approximately $969,100. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

As of the Q3 2025 filing, Bio-Techne Corporation (TECH) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Cliff Asness's peak holding in Bio-Techne Corporation (TECH) was 1,491,280 shares, as reported at the end of Q4 2018. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.